Discrete Aspects of FGF21 In Vivo Pharmacology Do Not Require UCP1
- PMID: 25956583
- DOI: 10.1016/j.celrep.2015.04.046
Discrete Aspects of FGF21 In Vivo Pharmacology Do Not Require UCP1
Abstract
A primary target of the pleiotropic metabolic hormone FGF21 is adipose tissue, where it initiates a gene expression program to enhance energy expenditure, an effect presumed to be centered on augmented UCP1 expression and activity. In UCP1 null (UCP1KO) mice, we show that the effect of FGF21 to increase the metabolic rate is abolished. However, in contrast to prior expectations, we found that increased UCP1-dependent thermogenesis is only partially required to achieve the beneficial effects of FGF21 treatment. In UCP1KO mice, there appears to be an underlying reduction in food intake following FGF21 administration, facilitating weight loss equal to that observed in wild-type animals. Furthermore, we show that UCP1-dependent thermogenesis is not required for FGF21 to improve glycemic control or to reduce circulating cholesterol or free fatty acids. These data indicate that several important metabolic endpoints of FGF21 are UCP1 independent; however, the contribution of UCP1-dependent thermogenesis to other discrete aspects of FGF21 biology requires further study.
Copyright © 2015 The Authors. Published by Elsevier Inc. All rights reserved.
Comment in
-
The sum of all browning in FGF21 therapeutics.Cell Metab. 2015 Jun 2;21(6):795-6. doi: 10.1016/j.cmet.2015.05.018. Cell Metab. 2015. PMID: 26039444
Similar articles
-
FGF21 mimetic antibody stimulates UCP1-independent brown fat thermogenesis via FGFR1/βKlotho complex in non-adipocytes.Mol Metab. 2017 Nov;6(11):1454-1467. doi: 10.1016/j.molmet.2017.09.003. Epub 2017 Sep 18. Mol Metab. 2017. PMID: 29107292 Free PMC article.
-
Long-Term Cold Adaptation Does Not Require FGF21 or UCP1.Cell Metab. 2017 Aug 1;26(2):437-446.e5. doi: 10.1016/j.cmet.2017.07.016. Cell Metab. 2017. PMID: 28768181
-
FGF21-Mediated Improvements in Glucose Clearance Require Uncoupling Protein 1.Cell Rep. 2015 Nov 24;13(8):1521-7. doi: 10.1016/j.celrep.2015.10.021. Epub 2015 Nov 12. Cell Rep. 2015. PMID: 26586424
-
Metabolic consequences of the presence or absence of the thermogenic capacity of brown adipose tissue in mice (and probably in humans).Int J Obes (Lond). 2010 Oct;34 Suppl 1:S7-16. doi: 10.1038/ijo.2010.177. Int J Obes (Lond). 2010. PMID: 20935668 Review.
-
UCP1: its involvement and utility in obesity.Int J Obes (Lond). 2008 Dec;32 Suppl 7(Suppl 7):S32-8. doi: 10.1038/ijo.2008.236. Int J Obes (Lond). 2008. PMID: 19136989 Free PMC article. Review.
Cited by
-
Effects of swimming in cold water on lipolysis indicators via fibroblast growth factor-21 in male Wistar rats.Biochem Biophys Rep. 2024 Feb 13;38:101662. doi: 10.1016/j.bbrep.2024.101662. eCollection 2024 Jul. Biochem Biophys Rep. 2024. PMID: 38375421 Free PMC article.
-
Fibroblast growth factor 21: An emerging pleiotropic regulator of lipid metabolism and the metabolic network.Genes Dis. 2023 Aug 2;11(3):101064. doi: 10.1016/j.gendis.2023.06.033. eCollection 2024 May. Genes Dis. 2023. PMID: 38292170 Free PMC article. Review.
-
The Role of the FGF19 Family in the Pathogenesis of Gestational Diabetes: A Narrative Review.Int J Mol Sci. 2023 Dec 9;24(24):17298. doi: 10.3390/ijms242417298. Int J Mol Sci. 2023. PMID: 38139126 Free PMC article. Review.
-
Hyperphagia of female UCP1-deficient mice blunts anti-obesity effects of FGF21.Sci Rep. 2023 Jun 24;13(1):10288. doi: 10.1038/s41598-023-37264-0. Sci Rep. 2023. PMID: 37355753 Free PMC article.
-
The potential function and clinical application of FGF21 in metabolic diseases.Front Pharmacol. 2022 Dec 21;13:1089214. doi: 10.3389/fphar.2022.1089214. eCollection 2022. Front Pharmacol. 2022. PMID: 36618930 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
